Plaintiffs in Breast Cancer Gene Suit Hope To Overturn Patent Policy
‘If you walk out into the street and tell someone that a company owns their genes, they’ll look at you strangely,” said Barbara Brenner, executive director of Breast Cancer Action. “But that is exactly what has happened.” Brenner’s group is one of several plaintiffs in a lawsuit recently filed in federal court challenging patents controlled…